Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Pediatric dyslipidemias: Prescription medication efficacy and safety.

Browne B, Vasquez S.

J Clin Lipidol. 2008 Jun;2(3):189-201. doi: 10.1016/j.jacl.2008.04.008. Epub 2008 Apr 12.

PMID:
21291737
2.

Combined therapy in the treatment of dyslipidemia.

Reiner Z.

Fundam Clin Pharmacol. 2010 Feb;24(1):19-28. doi: 10.1111/j.1472-8206.2009.00764.x. Epub 2009 Aug 14. Review.

PMID:
19682080
3.

Pharmacology and therapeutics of ezetimibe (SCH 58235), a cholesterol-absorption inhibitor.

Jeu L, Cheng JW.

Clin Ther. 2003 Sep;25(9):2352-87. Review.

PMID:
14604738
4.

Optimal management of combined dyslipidemia: what have we behind statins monotherapy?

Tenenbaum A, Fisman EZ, Motro M, Adler Y.

Adv Cardiol. 2008;45:127-53. doi: 10.1159/0000115192. Review.

PMID:
18230960
5.

The use of proton pump inhibitors in children: a comprehensive review.

Gibbons TE, Gold BD.

Paediatr Drugs. 2003;5(1):25-40. Review.

PMID:
12513104
6.
7.

Dose-response characteristics of cholesterol-lowering drug therapies: implications for treatment.

Schectman G, Hiatt J.

Ann Intern Med. 1996 Dec 15;125(12):990-1000. Review.

PMID:
8967711
9.

Pitavastatin calcium: clinical review of a new antihyperlipidemic medication.

Yee LL, Wright EA.

Clin Ther. 2011 Aug;33(8):1023-42. doi: 10.1016/j.clinthera.2011.07.011. Epub 2011 Aug 4. Review.

PMID:
21816477
10.

The safety of niacin in the US Food and Drug Administration adverse event reporting database.

Alsheikh-Ali AA, Karas RH.

Am J Cardiol. 2008 Apr 17;101(8A):9B-13B. doi: 10.1016/j.amjcard.2008.02.027. Review.

PMID:
18375244
11.

Pediatric migraine: pharmacologic agents for prophylaxis.

Eiland LS, Jenkins LS, Durham SH.

Ann Pharmacother. 2007 Jul;41(7):1181-90. Epub 2007 Jun 5. Review.

PMID:
17550953
12.

The role of colesevelam hydrochloride in hypercholesterolemia and type 2 diabetes mellitus.

Brunetti L, Hermes-Desantis ER.

Ann Pharmacother. 2010 Jul-Aug;44(7-8):1196-206. doi: 10.1345/aph.1M728. Epub 2010 Jun 15. Review.

PMID:
20551301
13.

Management of hypercholesterolemia in childhood and adolescence.

Kronn DF, Sapru A, Satou GM.

Heart Dis. 2000 Sep-Oct;2(5):348-53. Review.

PMID:
11728281
14.
15.

Pharmacologic management of insomnia in children and adolescents: consensus statement.

Mindell JA, Emslie G, Blumer J, Genel M, Glaze D, Ivanenko A, Johnson K, Rosen C, Steinberg F, Roth T, Banas B.

Pediatrics. 2006 Jun;117(6):e1223-32.

PMID:
16740821
16.

Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis.

Liu HY, Potter MP, Woodworth KY, Yorks DM, Petty CR, Wozniak JR, Faraone SV, Biederman J.

J Am Acad Child Adolesc Psychiatry. 2011 Aug;50(8):749-62.e39. doi: 10.1016/j.jaac.2011.05.011. Epub 2011 Jul 13. Review.

PMID:
21784295
17.

Emerging antidyslipidemic drugs.

Pollex RL, Joy TR, Hegele RA.

Expert Opin Emerg Drugs. 2008 Jun;13(2):363-81. doi: 10.1517/14728214.13.2.363 . Review.

PMID:
18537526
18.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
19.

Pediatric allergy medications: review of currently available formulations.

Scadding G.

Curr Med Res Opin. 2009 Aug;25(8):2069-79. doi: 10.1185/03007990903116875. Review.

PMID:
19580371
20.

What combination therapy with a statin, if any, would you recommend?

Dujovne CA, Williams CD, Ito MK.

Curr Atheroscler Rep. 2011 Feb;13(1):12-22. doi: 10.1007/s11883-010-0150-3. Review.

PMID:
21107758

Supplemental Content

Support Center